Hypothyroidism as an Independent Predictor of 30‐day Readmission in Head and Neck Cancer Patients
Open Access
- 28 March 2023
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 133 (11) , 2988-2998
Abstract
Objectives: To define the role of hypothyroidism and other risk factors for unplanned readmissions after surgery for head and neck cancer.Study Design: Retrospective cohort study.Methods: The Nationwide Readmission Database (NRD) was used to identify patients who underwent surgery for mucosal head and neck cancer (oral cavity, oropharynx, larynx, and hypopharynx) between 2010 and 2017. Univariate and multivariate logistic regression were performed to determine patient, tumor, and hospital related risk factors for 30‐day readmission. Readmitted patients were stratified by preoperative diagnosis of hypothyroidism to compare readmission characteristics.Results: For the 131,013 patients who met inclusion criteria, the readmission rate was 15.9%. Overall, 11.91% of patients had a preoperative diagnosis of hypothyroidism. After controlling for other variables, patients with a preoperative diagnosis of hypothyroidism had 12.2% higher odds of readmission compared to those without hypothyroidism (OR: 1.12, 1.03–1.22, p = 0.008). Patients with hypothyroidism had different reasons for readmission, including higher rates of wound dehiscence, fistula, infection, and electrolyte imbalance. Among readmitted patients, the length of stay for index admission (mean 10.5 days vs. 9.2 days, p < 0.001), readmission (mean 7.0 vs. 6.6 days, p = 0.05), and total hospital charge were higher for hypothyroid patients ($137,742 vs. $119,831, p < 0.001).Conclusion: Hypothyroidism is an independent risk factor for 30‐day readmission following head and neck cancer resection. Furthermore, hypothyroid patients are more likely to be readmitted for wound complications, infection, and electrolyte imbalance. Targeted interventions should be considered for hypothyroid patients to decrease readmission rates and associated patient morbidity, potentially leading to earlier initiation of adjuvant treatment.Level of Evidence: 3 Laryngoscope, 133:2988–2998, 2023Keywords
This publication has 56 references indexed in Scilit:
- Thyroid Hormone and Wound HealingJournal of Thyroid Research, 2013
- Thyroid Hormone Enhances Nitric Oxide-Mediated Bacterial Clearance and Promotes Survival after Meningococcal InfectionPLOS ONE, 2012
- The epidemiology of thyroid diseaseBritish Medical Bulletin, 2011
- Thyroid Hormones as Modulators of Immune Activities at the Cellular LevelThyroid®, 2011
- Endocrine disorders: Causes of hyponatremia not to neglectAnnals of Medicine, 2010
- Understanding Radiation-Induced Vascular DiseaseJACC, 2010
- Factors determining length of the postoperative hospital stay after major head and neck cancer surgeryOral Oncology, 2008
- Effects of Prolongation of Overall Treatment Time Due To Unplanned Interruptions During Radiotherapy of Different Tumor Sites and Practical Methods for CompensationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Recovery of age‐dependent immunological deterioration in old mice by thyroxine treatmentJournal of Animal Physiology and Animal Nutrition, 2006
- Hypothyroidism in head and neck cancer patients: Experimental and clinical observationsThe Laryngoscope, 1994